Evidence map›Paper›PMID 41079824›Full record

ArticleClinical case reports2025

Untying the Next Genetic Thread in a Family With MEN2A Syndrome: A Case Report.

Riyaz Shrestha, Mohammad Adnan Adil, Binita Basnet, Himal Karki, Pukar Maskey, Samir Shrestha, Mohammad Nasim Alam

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Riyaz ShresthaDepartment of Surgery Patan Academy of Health Sciences Lalitpur Nepal.ORCID https://orcid.org/0000-0001-7685-828X
Mohammad Adnan AdilDepartment of Surgery Patan Academy of Health Sciences Lalitpur Nepal.ORCID https://orcid.org/0009-0003-0826-5572
Binita BasnetDepartment of Surgery Patan Academy of Health Sciences Lalitpur Nepal.ORCID https://orcid.org/0009-0007-0636-6221
Himal KarkiDepartment of Surgery Patan Academy of Health Sciences Lalitpur Nepal.ORCID https://orcid.org/0000-0002-7288-6811
Pukar MaskeyDepartment of Surgery Patan Academy of Health Sciences Lalitpur Nepal.
Samir ShresthaDepartment of Surgery Patan Academy of Health Sciences Lalitpur Nepal.ORCID https://orcid.org/0000-0002-6403-6702
Mohammad Nasim AlamDepartment of Surgery Patan Academy of Health Sciences Lalitpur Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple endocrine neoplasia type 2A (MEN2A) is a rare autosomal dominant syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and primary hyperparathyroidism. Early genetic screening is crucial for timely intervention. We report a familial case of MEN2A involving four affected members across two generations. The index patient, a 40-year-old male with prior MTC and pheochromocytoma, presented with recurrent adrenal disease. His 41-year-old sister was diagnosed with MTC and pheochromocytoma despite negative genetic testing. The youngest sibling (37 years) and the index patient's 18-year-old son were diagnosed with MTC, with the former testing positive for a RET mutation. All underwent appropriate surgeries with ongoing surveillance. This case highlights the variable clinical presentation and genetic penetrance of MEN2A within a single family. It underscores the importance of genetic screening in all MTC patients and their first-degree relatives, as early identification of asymptomatic carriers enables timely prophylactic interventions.

Indexed as

genetic screeningmedullary thyroid carcinomaMEN2Apartial adrenalectomypheochromocytoma

Identifiers

PMID41079824
PMCPMC12514182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.